UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000017345
Receipt No. R000020128
Official scientific title of the study Search of related factors with the hypoglycemia in use of the antibiotic containing pivoxyl group against infants
Date of disclosure of the study information 2015/05/01
Last modified on 2017/03/14 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Search of related factors with the hypoglycemia in use of the antibiotic containing pivoxyl group against infants
Title of the study (Brief title) Antibiotic containing pivoxyl group and infants with hypoglycemia
Region
Japan

Condition
Condition Hypoglycemia
Classification by specialty
Pediatrics Child
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 The antibiotic containing pivoxyl group may cause hypoglycemia with hyper carnitinemia in long use of it. It is need for monitoring of it at the age from 0 to 5 years-old. This study investigates the transition of the urine and serum concentration of carnine and acyl-carnibitine and search of the useful factor for early prediction of hypoglycemia in use of antibiotic containing pivoxyl group.
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes The urine and serum concentration of carnitine and acyl-carnitine, plasma glucose level, biochemical laboratory data.
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
0 years-old <=
Age-upper limit
5 years-old >=
Gender Male and Female
Key inclusion criteria The infant patient taking the antibiotic containing pivoxyl group
Key exclusion criteria No
Target sample size

Research contact person
Name of lead principal investigator Nariyasu Mano
Organization Tohoku university hospital
Division name Department of pharmaceutical sciences
Address 1-1 Seiryo-machi, Aoba-ku, Sendai
TEL 022-717-7525
Email mano@hosp.tohoku.ac.jp

Public contact
Name of contact person Masamitsu Maekawa
Organization Tohoku university hospital
Division name Department of pharmaceutical sciences
Address 1-1 Seiryo-machi, Aoba-ku, Sendai
TEL 022-717-7541
Homepage URL
Email m-maekawa@hosp.tohoku.ac.jp

Sponsor
Institute Department of pharmaceutical sciences, Tohoku university hospital
Institute
Department

Funding Source
Organization Grant-in-Aid
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor Division of pediatrics, Tohoku university hospital
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 東北大学病院

Other administrative information
Date of disclosure of the study information
2015 Year 05 Month 01 Day

Progress
Recruitment status Completed
Date of protocol fixation
2014 Year 12 Month 15 Day
Anticipated trial start date
2014 Year 12 Month 25 Day
Last follow-up date
2016 Year 12 Month 31 Day
Date of closure to data entry
2016 Year 12 Month 31 Day
Date trial data considered complete
2016 Year 12 Month 31 Day
Date analysis concluded
2016 Year 12 Month 31 Day

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results However a simultaneous analytical method for carnnitine metabolites and the antibiotic drug was developed, no samples from patients with adverse effects by antibiotics having pivoxyl group were recruited.
Other related information The blood and urine concentration of carnitine and acyl-carnitine of patient with taking the antibiotic containing pivoxyl group are analyzed by LC/MS/MS and the factors related with adverse effect are searched.

Management information
Registered date
2015 Year 04 Month 30 Day
Last modified on
2017 Year 03 Month 14 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000020128